LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Repurposing of artesunate, an antimalarial drug, as a potential inhibitor of hepatitis E virus.

    Bhise, Neha / Agarwal, Megha / Thakur, Nidhi / Akshay, P S / Cherian, Sarah / Lole, Kavita

    Archives of virology

    2023  Volume 168, Issue 5, Page(s) 147

    Abstract: Hepatitis E virus (HEV) is endemic in several developing countries of Africa and Asia. It mainly causes self-limiting waterborne infections, in either sporadic or outbreak form. Recently, HEV was shown to cause chronic infections in immunosuppressed ... ...

    Abstract Hepatitis E virus (HEV) is endemic in several developing countries of Africa and Asia. It mainly causes self-limiting waterborne infections, in either sporadic or outbreak form. Recently, HEV was shown to cause chronic infections in immunosuppressed individuals. Ribavirin and interferon, the current off-label treatment options for hepatitis E, have several side effects. Hence, there is a need for new drugs. We evaluated the antimalarial drug artesunate (ART) against genotype 1 HEV (HEV-1) and HEV-3 using a virus-replicon-based cell culture system. ART exhibited 59% and 43% inhibition of HEV-1 and HEV-3, respectively, at the highest nontoxic concentration. Computational molecular docking analysis showed that ART can bind to the helicase active site (affinity score, -7.4 kcal/mol), indicating its potential to affect ATP hydrolysis activity. An in vitro ATPase activity assay of the helicase indeed showed 24% and 55% inhibition at 19.5 µM (EC
    MeSH term(s) Female ; Pregnancy ; Animals ; Humans ; Hepatitis E virus/genetics ; Artesunate/pharmacology ; Artesunate/therapeutic use ; Antimalarials/pharmacology ; Drug Repositioning ; Molecular Docking Simulation ; Virus Replication ; Hepatitis E/drug therapy ; RNA-Dependent RNA Polymerase/genetics ; Adenosine Triphosphate
    Chemical Substances Artesunate (60W3249T9M) ; Antimalarials ; RNA-Dependent RNA Polymerase (EC 2.7.7.48) ; Adenosine Triphosphate (8L70Q75FXE)
    Language English
    Publishing date 2023-04-28
    Publishing country Austria
    Document type Journal Article
    ZDB-ID 7491-3
    ISSN 1432-8798 ; 0304-8608
    ISSN (online) 1432-8798
    ISSN 0304-8608
    DOI 10.1007/s00705-023-05770-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Correction to: Repurposing of artesunate, an antimalarial drug, as a potential inhibitor of hepatitis E virus.

    Bhise, Neha / Agarwal, Megha / Thakur, Nidhi / Akshay, P S / Cherian, Sarah / Lole, Kavita

    Archives of virology

    2023  Volume 168, Issue 7, Page(s) 193

    Language English
    Publishing date 2023-06-28
    Publishing country Austria
    Document type Published Erratum
    ZDB-ID 7491-3
    ISSN 1432-8798 ; 0304-8608
    ISSN (online) 1432-8798
    ISSN 0304-8608
    DOI 10.1007/s00705-023-05799-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top